visugromab Archives - European Biotechnology Magazine

Tag Archive for: visugromab

CatalYm GmbH raises €50m to push visugromab development

Munich-based immunooncology specialist CatalYm GmbH wants to use €50m from a Series C financing round to advance its anti-GDF15 antibody to Phase II development.

22 November 2022

CatalYm GmbH raises €50m to push visugromab development

UK to boost scale-up of biomanufacturing infrastruc...

Sanofi to acquire Dren Bio’s bispecific myeloid c...

Brainomix Ltd. completes £14m Series C financing

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

The Bridge to your success

Stay up to date every week with the european biotechnology newsletter.

Stay up to date every week with the european biotechnology newsletter.

Tag Archive for: visugromab